Absolute risk of alopecia was low, however

Absolute risk of alopecia was low, however

The study looked at 50,000 people on the drugs

The use of glucagon-like peptide-1 (GLP-1) receptor agonists to treat type 2 diabetes and obesity is associated with an increased risk of hair loss (alopecia) in adults with type…

GLP-1 drugs such as Wegovy and Ozempic have been revolutionary for obesity and type 2 diabetes treatments, but questions remain about some of the side effects and potential…

Jump to contentThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged…

People on GLP-1 agonist drugs such as Mounjaro, Ozempic and Wegovy have been reporting hair loss